Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer

Published:2008 Issue:3 Volume:26 Page:160
ISSN:1229-8719
Container-title:The Journal of the Korean Society for Therapeutic Radiology and Oncology
language:
Short-container-title:J Korean Soc Ther Radiol Oncol

Author:

Oak Chul Ho¹,Kim Ja Kyung¹,Jang Lee La¹,Moon Dae Sung¹,Jang Tae Won¹,Jung Maan Hong¹,Cho Sung Whan²,Jeung Tae Sig³

Affiliation:

1. Department of Internal Medicine, College of Medicine, Kosin University, Busan, Korea.

2. Department of Internal Medicine, Busan Veterans Hospital, Busan, Korea.

3. Department of Radiation Oncology, College of Medicine, Kosin University, Busan, Korea.

Publisher

Korean Society for Therapeutic Radiology and Oncology

Link

http://synapse.koreamed.org/pdf/10.3857/jkstro.2008.26.3.160

Reference25 articles.

1. Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial

2. Five-Year Survival After Hyperfractionated Radiation Therapy for Non-Small-Cell Carcinoma of the Lung (NSCCL)

3. Treatment of Stage IIIA Non-small Cell Lung Cancer*

4. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP